MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X952. A total of 3 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -94.9% | 6,600 | -83.2% | 0.00% | – |
| Q2 2023 | $59 | +391.7% | 39,400 | +432.4% | 0.00% | – |
| Q1 2023 | $12 | +100.0% | 7,400 | +37.0% | 0.00% | – |
| Q4 2022 | $6 | -100.0% | 5,400 | -11.5% | 0.00% | – |
| Q3 2022 | $15,000 | +114.3% | 6,100 | +281.2% | 0.00% | – |
| Q1 2022 | $7,000 | -79.4% | 1,600 | -71.9% | 0.00% | – |
| Q4 2021 | $34,000 | – | 5,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 13,200 | $7,814 | 0.00% |
| SIMPLEX TRADING, LLC | 6,600 | $3 | 0.00% |